ETFsXtrackers MSCI Europe High Dividend Yield ESG UCITS ETF 1D
Xtrackers
Xtrackers MSCI Europe High Dividend Yield ESG UCITS ETF 1D
XZDE XETRADistributingIreland
Last close · EUR
41.78EUR
+0.17% · +€0.07
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
XZDEBase
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- +18.4%
- Sharpe 3Y
- 1.13
- Volatility 1Y
- 11.8%annualised
- Holdings
- 88Fund holdings
Performance
Compare
- XZDE+18.4%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| XZDE | +4.4% | +2.0% | +8.2% | +13.7% | +18.4% | +64.4% | - |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.0% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | +4.0% | -2.9% | -2.6% | -2.4% | +2.5% | -11.1% | - |
Risk and return
Sharpe ratio · 3Y
1.13
Below MSCI World · 1.24- Return p.a.
- +16.9%
- Volatility
- 11.9%
- Max loss
- -15.4%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
XZDE
1.13
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 40.0%
- Holdings
- 88
- As of
- 1NOVARTIS AGCH00120052675.37%
- 2SAPDE00071646005.12%
- 3ASML HOLDINGNL00102732154.05%
- 4DHL N AGDE00055520043.99%
- 5ROCHE PS PAR AGCH14990599833.94%
- 6ZURICH INSURANCE GROUP AGCH00110753943.81%
- 7SANOFI SAFR00001205783.73%
- 8ALLIANZDE00084040053.72%
- 9AXA SAFR00001206283.55%
- 10RIO TINTOGB00071887572.76%
Countries
Classified 100.0%
Germany19.3%
Switzerland18.3%
GB
NL
France10.2%
Sweden10.0%
IT
DK
FI
AU
ES
- Largest
- 19.3%Germany
- Top 3
- 51.8%
- Effective number
- 7.91 / HHI
Market cap
Weight vs holdings
40.0%of the fund sits in the top 10 holdings
40.0%46.3%13.6%
WeightHoldings
104038
- Holdings 1-10
- Holdings 11-50
- Holdings 51-88
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
